EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drug
BRUSSELS -- The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its…